Peritoneal Dialysis Versus Haemodialysis

Clinical Study in Order to Quantify Solute Removal in Peritoneal Dialysis Versus Haemodialysis

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00752583

Enrollment

Registered

2008-09-15

Start date

2008-11-07

Completion date

2015-12-31

Last updated

2022-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis

Keywords

Chronic renal insufficiency (patients under dialysis)

Brief summary

Study in order to quantify toxin removal during dialysis

Interventions

PROCEDUREPeritoneal dialysis

Blood, urine and dialysate sampling

PROCEDUREHaemodialysis

Blood, urine and dialysate sampling

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Substudy 1: includes new starting dialysis patients on peritoneal dialysis PD or haemodialysis HD * Substudy 2: stabile haemodialysis patients and peritoneal dialysis patients. Patients will be matched for gender, time on dialysis, diabetes, renal function at the start of dialysis. * Substudy 3: patients on CAPD (continuous ambulant PD) or CCPD (continuous cyclic PD).

Design outcomes

Primary

Measure	Time frame
Registration of toxin removal efficiency	After 1 week and after 1, 3, 6, 9, 12, 18 and 24 months

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026